Skip to content
Back to Guavy Wire
Stocks

Kingsview Wealth Management Acquires New Stake in Amgen Inc.

Instruments
AMGN
Share

Kingsview Wealth Management LLC has acquired a new stake in Amgen Inc. (NASDAQ:AMGN) shares, valued at approximately $6.78 million. The fund bought 18,729 shares of the medical research company's stock during the second quarter.

This is not an isolated case; several institutional investors have modified their holdings in Amgen. BlackRock Inc., for example, grew its position by 4.8% and now owns 49,362,016 shares of Amgen's stock, valued at $17,874,974,000.

Amgen has been performing well financially, with a recent quarterly earnings report exceeding analyst expectations. The company reported $6.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.62 by $0.67.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc